Andrej Bešše
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
Papers in
-
- Ubiquitin and proteasome pathways 16
- Protein Degradation and Inhibitors 9
- Circular RNAs in diseases 7
- Histone Deacetylase Inhibitors Research 3
- Hematology 18
- Multiple Myeloma Research and Treatments 18
- Co-authors
- Ondřej Slabý (10 shared papers)Marek Svoboda (5 shared papers)Lenka Bešše (22 shared papers)Rostislav Vyzula (4 shared papers)Lenka Radová (5 shared papers)Christoph Driessen (25 shared papers)Pavel Fadrus (5 shared papers)Jiří Šáňa (5 shared papers)
- Journals
- Blood (7 papers)Tumor Biology (3 papers)Scientific Reports (2 papers)Cells (2 papers)iScience (1 paper)
- Partner nations
- SwitzerlandCzechiaNetherlands
In The Last Decade
Andrej Bešše
30 papers receiving 635 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 334
- Molecular Biology 501
- Hematology 78
- Genetics 45
- Oncology 99
Countries citing papers authored by Andrej Bešše
This map shows the geographic impact of Andrej Bešše's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Bešše with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Bešše more than expected).
Fields of papers citing papers by Andrej Bešše
This network shows the impact of papers produced by Andrej Bešše. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Bešše. The network helps show where Andrej Bešše may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrej Bešše, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 119 | |
| 2 | 2019 | 84 | |
| 3 | 2012 | 66 | |
| 4 | 2015 | 52 | |
| 5 | 2018 | 40 | |
| 6 | 2012 | 39 | |
| 7 | 2013 | 38 | |
| 8 | 2018 | 34 | |
| 9 | 2014 | 30 | |
| 10 | 2021 | 21 | |
| 11 | 2016 | 19 | |
| 12 | 2017 | 14 | |
| 13 | 2017 | 11 | |
| 14 | 2022 | 11 | |
| 15 | 2021 | 11 | |
| 16 | 2021 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 5 |
About Andrej Bešše
Andrej Bešše is a scholar working on Molecular Biology, Hematology, Oncology, Cancer Research and Infectious Diseases, having authored 35 papers that have together received 636 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Ubiquitin and proteasome pathways (16 papers), Protein Degradation and Inhibitors (9 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers), Peptidase Inhibition and Analysis (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Cancer Research (334 citations), Molecular Biology (501 citations), Hematology (78 citations), Genetics (45 citations) and Oncology (99 citations). Andrej Bešše has collaborated with scholars based in Switzerland, Czechia and Netherlands. Frequent co-authors include Ondřej Slabý, Marek Svoboda, Lenka Bešše, Rostislav Vyzula, Lenka Radová, Christoph Driessen, Pavel Fadrus, Jiří Šáňa, Jana Nekvindová and Radek Lakomý. Their work appears in journals such as Blood, Tumor Biology, Scientific Reports, Cells and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.